Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc.'s email is info@sorrentotherapeutics.com
and
Sorrento Therapeutics, Inc.'s phone number is (858) 210-3759
.
Sorrento Therapeutics is a development-stage biopharmaceutical company engaged in the acquisition, discovery, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs. Sorrento’s late stage pipeline include Cynviloq™ (paclitaxel in polymeric micelle formulation) currently in a registrational bio-equivalent study versus albumin-bound paclitaxel; and Resiniferatoxin (RTX),which is in a Phase 1/2 study at the NIH to treat terminal cancer patients suffering from intractable pain. Sorrento has one of the industry’s ...
read more
Sorrento Therapeutics is a development-stage biopharmaceutical company engaged in the acquisition, discovery, development and commercialization of proprietary drug therapeutics for addressing significant unmet medical needs. Sorrento’s late stage pipeline include Cynviloq™ (paclitaxel in polymeric micelle formulation) currently in a registrational bio-equivalent study versus albumin-bound paclitaxel; and Resiniferatoxin (RTX),which is in a Phase 1/2 study at the NIH to treat terminal cancer patients suffering from intractable pain. Sorrento has one of the industry’s most diverse antibody (G-MAB®) library comprised of high-quality, fully human antibodies with a diversity of more than ten trillion (>10^16). Along with its' proprietary conjugation chemistries and novel toxins, Sorrento has all in-house capabilities to generate and develop a new generation of homogenous ADCs with well-defined drug antibody ratios (DAR) in contrast to approved ADCs, which are heterogeneous mixtures with different DARs. These differentiating characteristics may lead to improved ADC stability and pharmacokinetics while reducing off-target effects compared to existing ADCs. Sorrento's primary therapeutic focus is cancer although its products and technologies have much broader clinical applications including autoimmune disorders, metabolic diseases and infectious diseases.
show less
Website | sorrentotherapeutics.com | |
Industry | Biotechnology | |
Location | San Diego, California, United States | |
Employees | 220 | |
Founded | 2006 |
HQ | 4955 Directors Pl Suite B | |
Phone | (858) 210-3759 | |
info@sorrentotherapeutics.com | ||
Funding | 264,418,495 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | sorrentotherapeutics.com | |
Industry | Biotechnology | |
Location | San Diego, California, United States | |
Employees | 220 | |
Founded | 2006 | |
linkedin.com/company/sorrento-therapeutics-inc. | ||
HQ | 4955 Directors Pl Suite B | |
Phone | (858) 210-3759 | |
info@sorrentotherapeutics.com | ||
Funding | 264,418,495 USD |
Email Patterns for Sorrento Therapeutics, Inc.
Top Competitors for Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc. Questions
Where are Sorrento Therapeutics, Inc.'s headquarters?
Sorrento Therapeutics, Inc.'s headquarters are in 4955 Directors Pl Suite B
What is Sorrento Therapeutics, Inc.'s phone number?
Sorrento Therapeutics, Inc.'s phone number is (858) 210-3759
What is Sorrento Therapeutics, Inc.'s official website?
Sorrento Therapeutics, Inc.'s website is sorrentotherapeutics.com
How many employees are working in Sorrento Therapeutics, Inc. right now?
Sorrento Therapeutics, Inc. has
220 employees.
View the Email and Phone Numbers for all 220 working at Sorrento Therapeutics, Inc..
What is Sorrento Therapeutics, Inc.'s industry?
Sorrento Therapeutics, Inc.'s industry is
Biotechnology
Who are Sorrento Therapeutics, Inc.'s top competitors?
Sorrento Therapeutics, Inc.'s top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Sorrento Therapeutics, Inc.'s email address?
Sorrento Therapeutics, Inc.'s email address is info@sorrentotherapeutics.com
What are Sorrento Therapeutics, Inc.'s categories?
Sorrento Therapeutics, Inc.'s categories are Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
What is Sorrento Therapeutics, Inc.'s location?
Sorrento Therapeutics, Inc.'s location is
San Diego, California, United States
When was Sorrento Therapeutics, Inc.'s founded?
Sorrento Therapeutics, Inc.'s founding year is 2006
What is Sorrento Therapeutics, Inc.'s funding?
Sorrento Therapeutics, Inc.'s funding is 264,418,495 USD
What is Sorrento Therapeutics, Inc.'s current status?
Sorrento Therapeutics, Inc.'s current status is ipo
Top Sorrento Therapeutics, Inc. Employees
Senior Vice President, General Counsel And Corporate Secretary
brianssun@gmail.com
+1703-548-6284
Chief Financial Officer
rvincent@genoapharma.com
+1858-210-3700
Research Associate
+1661-877-7426
Research Associate
leximae14@gmail.com
+1619-922-7550
System Administrator
imanjarrez@suncommunityfcu.org
+1760-337-4200
Director
htzhang@msn.com
+1646-334-8611
Senior Research Associate
ryanet_6688@hotmail.com
+1858-699-8145